SF Showcases: Eve Medical
Here at SocialFinance.ca, nothing excites us more than the opportunity to share stories about the great work happening in Canadian social finance! This goes double when the work is being done by our partners. A few months ago Trish Nixon introduced the 2nd cohort of Impact8, Ontario’s first social venture accelerator. Now with Impact8’s Demo Day just around the corner, we’re profiling this year’s Impact8 ventures. Today we’re chatting with Evan Moses, Co-Founder & COO of Eve Medical. The aim, as always, is to shine a light on folks in the field by lobbing a few questions their way: What problems are they tackling? What have they found to be best practices? Can this model be brought to scale and/or replicated? As always, we want your input on this and future profiles. Who would you like to know more about? What kind of stories do we need to tell more often? Whose lessons learned would you like to hear? Tweet us, Facebook us, or email us!
Thanks for chatting with us! To start us off, could you please tell us what Eve Medical does in a tweet (140 characters or less)?
Eve Medical is focused on reducing rates of cervical cancer by providing a user-friendly and resource-effective screening method.
Expanding from that answer, what is the problem that Eve Medical was conceived in order to address? What do you feel is unique about your approach to solving this problem?
Cervical cancer is preventable but more than 275,000 women still die from it every year. The vast majority of these deaths occur in women who don’t screen. There are a number of reasons for this: many women don’t have time or lack access to a doctor, while for others the test is embarrassing, uncomfortable or culturally sensitive. Eve Medical’s first product, HerSwab, is a device that makes it easy for women to collect their own samples at home to test for HPV, the virus that causes cervical cancer. We designed it together with women and doctors to ensure a simple, user-friendly process that produces high quality samples. This collection method reduces almost of the barriers to screening, and can increase screening participation among previously non-responding women.
What factors have been important for getting you to where you are today and what will you need to build on to take your venture to the next level?
A few years ago, HerSwab was just an idea, and today, it’s commercially available in Europe! We wouldn’t have been able to make it without the support of many people and organizations who contributed, and continue to contribute, their time, funds, experience and knowledge. In particular, our advisory board has been incredibly helpful in hashing out our strategy and making connections we need to grow. Going forward, we’re looking for new partners and capital to help us demonstrate the clinical and human impact that HerSwab can have in women’s lives.
Blue sky time! Where is your venture in 5 years? Where’s the marketplace? How big a dent have you made in the problem you’re tackling?
We’re in the middle of a sea change in the way that we screen for cervical cancer. We believe self-sampling can have a tremendous impact by making care more accessible and patient-friendly, saving lives in the process. Eve Medical wants to be part of making this happen. In 5 years, our aim is help a million women screen who wouldn’t have done so otherwise.
Editor’s Note: Stay tuned for more profiles of the amazing cohort of Impact8 social ventures!